Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Envista HoldingsMEX:NVST 80 EV-to-FCF is 21.03 as of Jul. 22, 2026, which is 4% below its 10-year median of 22.02. GuruFocus rates MEX:NVST with a GF Score™ of 80/100 and a GF Value™ of MXN332.83. The stock has 4 warning signs investors should review. Among 414 Medical Devices & Instruments companies, Envista Holdings ranks better than 53.38% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Envista Holdings's Enterprise Value is MXN85,165 Mil.
Envista Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was MXN4,050 Mil. Therefore, Envista Holdings's EV-to-FCF for today is 21.03.
The historical rank and industry rank for Envista Holdings's EV-to-FCF or its related term are showing as below:
MEX:NVST'
s EV-to-FCF Range Over the Past 10 Years
Min: 10.1 Med: 22.02 Max: 76.1
Current: 21.94
During the past 10 years, the highest EV-to-FCF of Envista Holdings was 76.10. The lowest was 10.10. And the median was 22.02.
MEX:NVST's EV-to-FCF is ranked better than 53.38% of 414
companies
in the Medical Devices & Instruments industry
Industry Median: 23.21
vs MEX:NVST: 21.94
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Envista Holdings's PE Ratio (TTM) for today is calculated as:
Envista Holdings's share price for today is MXN370.00.
Envista Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN7.418.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Envista Holdings EV-to-FCF Related Terms
Envista Holdings EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Envista Holdings's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:NVST vs MMSI, MMED, STVN: EV-to-FCF Comparison
For the Medical Instruments & Supplies subindustry, Envista Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Envista Holdings EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Envista Holdings's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Envista Holdings's EV-to-FCF falls into.
Envista Holdings's current Enterprise Value is MXN85,165 Mil.
Envista Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN4,050 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Envista Holdings (MEX:NVST) has a EV-to-FCF of 21.03 as of Jul. 22, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Envista Holdings and its competitors. This is near median its historical median of 22.02. Over the past decade, Envista Holdings' EV-to-FCF has ranged from 10.10 to 76.10. According to the industry distribution chart, Envista Holdings ranks #193 out of 414 companies in the Medical Devices & Instruments industry, placing it in the top 46.6%.
Is Envista Holdings' EV-to-FCF too high?
Envista Holdings' current EV-to-FCF of 21.03 is near median its 10-year median of 22.02. Over the past 10 years, this metric has ranged from a low of 10.10 to a high of 76.10. The Medical Devices & Instruments industry median EV-to-FCF is 23.21. Envista Holdings' value of 21.03 is 9.4% below this industry median. Based on the distribution chart, Envista Holdings ranks #193 out of 414 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Envista Holdings has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Envista Holdings' EV-to-FCF compare to MMSI and MMED?
According to the Medical Devices & Instruments industry distribution chart, Envista Holdings ranks #193 out of 414 companies for EV-to-FCF. This puts Envista Holdings in the upper half of its industry. The industry median EV-to-FCF is 23.21. Envista Holdings' value of 21.03 is 9.4% below this benchmark. Historically, Envista Holdings' own EV-to-FCF has ranged from 10.10 to 76.10 over the past decade. While the company's 10-year median is 22.02 vs. the industry median of 23.21, Envista Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.21, based on 414 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Envista Holdings's current EV-to-FCF of 21.03 is 9.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Envista Holdings and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Envista Holdings's current EV-to-FCF is 21.03, which is near median its own 10-year median of 22.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Envista Holdings stock overvalued right now?
Envista Holdings (MEX:NVST) has a current EV-to-FCF of 21.03. The stock's GF Value™ is MXN332.83, compared to a current price of MXN370.00 — trading 11.2% above its estimated fair value. The current EV-to-FCF is 21.03, which is near median its 10-year median of 22.02 and 9.4% below the Medical Devices & Instruments industry median of 23.21. Envista Holdings' overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Envista Holdings (MEX:NVST), the current EV-to-FCF is 21.03 as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Envista Holdings (MEX:NVST) Overvalued in 2026?
Based on GuruFocus' analysis, Envista Holdings stock appears to be overvalued.
The current stock price of MXN370.00 is trading 11.2% above its estimated GF Value™ of MXN332.83.
Key valuation signals for MEX:NVST:
EV-to-FCF: 21.03 (near median its 10-year median of 22.02)
GF Value™: MXN332.83 vs. price of MXN370.00 (11.2% above fair value)
Industry Position: 9.4% below the Medical Devices & Instruments median (#193 of 414)
No single metric tells the full story. See the MEX:NVST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.
80GF Score
Get the complete analysis for MEX:NVST
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:NVST has been successfully added to your 
